BDTX · Black Diamond Therapeutics Inc
United States · RS rating 15 · As of 2026-10-14
| Price | 1.70 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 17 / 41 / 12 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 20 / 17 / 6 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -80.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +65.1% |
| Market cap (USD) | $177.6M |